Literature DB >> 21712710

For the love of paradox: from neurobiology to pharmacology.

Richard A Bond1, Heather Giles.   

Abstract

The acute and chronic effects of certain drugs can often be opposite. For example, in congestive heart failure acute administration of β-adrenoceptor agonists results in beneficial improvement in symptoms of the disease, but their chronic use increases mortality. Conversely, certain β-adrenoceptor antagonists/inverse agonists (β-blockers) initially cause a detrimental response by decreasing cardiac contractility in congestive heart failure, whereas chronic treatment with the same β-blockers improves contractility and survival. Furthermore, this time-dependent reversal of outcomes occurs in nonpharmacological interventions, such as exercise, and can even be observed in the response of plants to pruning or other stressors, with the results being a different short-term versus long-term effect. Here, we review some of these phenomena with a special emphasis on the temporal dissociation of pharmacological effects. Although Francis Colpaert used this knowledge to lead a drug discovery project for an analgesic compound that initially produced hyperalgesia, we focused on examples outside the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21712710      PMCID: PMC3155657          DOI: 10.1097/FBP.0b013e328348ec6f

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  25 in total

Review 1.  beta-adrenergic receptor blockade in chronic heart failure.

Authors:  M R Bristow
Journal:  Circulation       Date:  2000-02-08       Impact factor: 29.690

Review 2.  Is paradoxical pharmacology a strategy worth pursuing?

Authors:  R A Bond
Journal:  Trends Pharmacol Sci       Date:  2001-06       Impact factor: 14.819

Review 3.  Can intellectualism stifle scientific discovery?

Authors:  Richard A Bond
Journal:  Nat Rev Drug Discov       Date:  2002-10       Impact factor: 84.694

Review 4.  New perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma.

Authors:  J K L Walker; R B Penn; N A Hanania; B F Dickey; R A Bond
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

5.  Response to salbutamol in patients with mild asthma treated with nadolol.

Authors:  N A Hanania; B Mannava; A E Franklin; B J Lipworth; P A Williamson; W J Garner; B F Dickey; R A Bond
Journal:  Eur Respir J       Date:  2010-10       Impact factor: 16.671

Review 6.  beta-Adrenoceptor inverse agonists in asthma.

Authors:  Burton F Dickey; Julia K L Walker; Nicola A Hanania; Richard A Bond
Journal:  Curr Opin Pharmacol       Date:  2010-06       Impact factor: 5.547

Review 7.  Emerging gonadotropin-releasing hormone agonists.

Authors:  Daniel Alexander Beyer; Feriel Amari; Marc Thill; Askan Schultze-Mosgau; Safaa Al-Hasani; Klaus Diedrich; Georg Griesinger
Journal:  Expert Opin Emerg Drugs       Date:  2011-01-19       Impact factor: 4.191

Review 8.  Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis.

Authors:  João Batista A Oliveira; Ricardo Baruffi; Cláudia G Petersen; Ana L Mauri; Mario Cavagna; José G Franco
Journal:  Reprod Biol Endocrinol       Date:  2010-09-08       Impact factor: 5.211

9.  Role of spinal 5-HT(1A) receptors in morphine analgesia and tolerance in rats.

Authors:  Laurent Bardin; Francis C Colpaert
Journal:  Eur J Pain       Date:  2004-06       Impact factor: 3.931

10.  Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma.

Authors:  Zsuzsanna Callaerts-Vegh; Kenda L J Evans; Noornabi Dudekula; Donald Cuba; Brian J Knoll; Patrick F K Callaerts; Heather Giles; Felix R Shardonofsky; Richard A Bond
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-06       Impact factor: 11.205

View more
  1 in total

1.  Impact of β-Blockers on Heart Rate and Oxygen Uptake During Exercise and Recovery in Older Patients With Heart Failure With Preserved Ejection Fraction.

Authors:  Sara Maldonado-Martín; Peter H Brubaker; Cemal Ozemek; Jon A Jayo-Montoya; J Thomas Becton; Dalane W Kitzman
Journal:  J Cardiopulm Rehabil Prev       Date:  2020-05       Impact factor: 3.646

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.